Soheil Hassanipour1, Majid Mohammadzadeh2, Fariborz Mansour-Ghanaei3, Mohammad Fathalipour4, Farahnaz Joukar1, Hamid Salehiniya5,6, Elham Abdzadeh7, Ali Akbar Samadani1, Hossein-Ali Nikbakht8, Morteza Arab-Zozani9. 1. Gastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran. 2. Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran. 3. Gastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran. fmansourghanaei@gmail.com. 4. Department of Pharmacology and Toxicology, Faculty of Pharmacy, Hormozgan University of Medical Sciences, Bandar Abbas, Iran. 5. Zabol University of Medical Sciences, Zabol, Iran. 6. Department of Epidemiology and Biostatistics, Tehran University of medical sciences, Tehran, Iran. 7. Department of Biology, Faculty of Science, University of Guilan, Rasht, Iran. 8. Social Determinants of Health Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran. 9. Iranian Center of Excellence in Health Management, School of Management and Medical Informatics, Tabriz University of Medical Sciences, Tabriz, Iran.
Abstract
PURPOSE: Hepatocellular carcinoma or liver cancer (LC) is one of most important cancer around the world. There are several reports about LC incidence from various Iranian locations with conflicting results. The present study aimed to accomplish a systematic review to estimate the accurate incidence rate of LC among Iranian people. METHODS: This systematic review was performed based on the preferred reporting items for systematic reviews and meta-analyses (PRISMA) checklist in 2018. A literature search was conducted using international databases (Medline/PubMed, Scopus, ScienceDirect, and Google Scholar) for English papers and national databases (Scientific Information Database, MagIran, IranMedex, and IranDoc) for Persian papers which estimated incidence rate of LC in any geographical area of Iran. The incidence rate of LC was calculated using random effect model. RESULTS: Of 171 papers in the primary searches, 15 studies were included by advanced screening and refinement. The age-standardized rate (ASR) of LC was 1.66 (95% CI 1.49-1.83) for males and 1.25 (95% CI 1.12-1.38) for females. CONCLUSIONS: The incidence rate of LC in Iran was lower in comparison to other countries. Afterwards, more studies are necessary to outline the accurate incidence rate and the trend of LC among Iranian population.
PURPOSE:Hepatocellular carcinoma or liver cancer (LC) is one of most important cancer around the world. There are several reports about LC incidence from various Iranian locations with conflicting results. The present study aimed to accomplish a systematic review to estimate the accurate incidence rate of LC among Iranian people. METHODS: This systematic review was performed based on the preferred reporting items for systematic reviews and meta-analyses (PRISMA) checklist in 2018. A literature search was conducted using international databases (Medline/PubMed, Scopus, ScienceDirect, and Google Scholar) for English papers and national databases (Scientific Information Database, MagIran, IranMedex, and IranDoc) for Persian papers which estimated incidence rate of LC in any geographical area of Iran. The incidence rate of LC was calculated using random effect model. RESULTS: Of 171 papers in the primary searches, 15 studies were included by advanced screening and refinement. The age-standardized rate (ASR) of LC was 1.66 (95% CI 1.49-1.83) for males and 1.25 (95% CI 1.12-1.38) for females. CONCLUSIONS: The incidence rate of LC in Iran was lower in comparison to other countries. Afterwards, more studies are necessary to outline the accurate incidence rate and the trend of LC among Iranian population.
Authors: Jacques Ferlay; Hai-Rim Shin; Freddie Bray; David Forman; Colin Mathers; Donald Maxwell Parkin Journal: Int J Cancer Date: 2010-12-15 Impact factor: 7.396
Authors: Willscott E Naugler; Toshiharu Sakurai; Sunhwa Kim; Shin Maeda; Kyounghyun Kim; Ahmed M Elsharkawy; Michael Karin Journal: Science Date: 2007-07-06 Impact factor: 47.728
Authors: Alireza Sadjadi; Reza Malekzadeh; Mohammad H Derakhshan; Alireza Sepehr; Mehdi Nouraie; Masoud Sotoudeh; Abbas Yazdanbod; Behrooz Shokoohi; Afshin Mashayekhi; Shahnam Arshi; Ali Majidpour; Masoud Babaei; Alireza Mosavi; Mohammad Ali Mohagheghi; Masomeh Alimohammadian; Mohammad Ali Mohagheghi Mosavi Journal: Int J Cancer Date: 2003-10-20 Impact factor: 7.396
Authors: Mohammad H Somi; Sara Farhang; S Kazem Mirinezhad; Shahnaz Naghashi; Mehran Seif-Farshad; Mehrad Golzari Journal: Asian Pac J Cancer Prev Date: 2008 Apr-Jun